$FOCL News
Last published 6d ago
- 6d agoFOCLEDAP TMS SA - EXHIBIT 99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 6d agoFOCLFocalTherics™ Reports Third Quarter 2026 Financial ResultsGlobeNewswireFocalTherics™ Reports Third Quarter 2026 Financial Results 45% Revenue Increase and 44% Growth in U.S. Procedure Volume Year-to-date AUSTIN, Texas, Nov. 05, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (NASDAQ:FOCL) (the
- 1w agoFOCLFocalTherics™ to Participate in Upcoming Investor ConferencesGlobeNewswireFocalTherics™ to Participate in Upcoming Investor Conferences AUSTIN, Texas, Nov. 04, 2026 (GLOBE NEWSWIRE) -- FocalTherics (NASDAQ:FOCL) (the "Company"), a global leader in robotic focal therapy, today
- 2w agoFOCLFocalTherics™ to Announce Third Quarter 2026 Financial Results on November 5, 2026GlobeNewswireFocalTherics™ to Announce Third Quarter 2026 Financial Results on November 5, 2026 Company to host conference call and webcast on Thursday, November 5 at 4:30 p.m. ET AUSTIN, Texas, Oct. 22, 2026 (GLOBE NEWSWIRE) --
- 2mo agoFOCLFocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment ConferenceGlobeNewswireFocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference Company to Present and Host 1x1 Investor Meetings on Tuesday and Wednesday, September 15th-16th, 2026 AUSTIN, Texas, Sept.
- 3mo agoEDAPFOCLFocalTherics (Formerly EDAP) Second Quarter 2026 Earnings Conference Call - EDAP TMS SAEarnings Call TranscriptsGood afternoon, everyone. Welcome to today's Focal Therix second quarter 2026 conference call. At this time, all participants are in a listen-only mode. After the prepared remarks, you will have the opportunity to ask qu
- 3mo agoEDAPFOCLFocalTherics (Formerly EDAP) Second Quarter 2026 Earnings Conference Call - EDAP TMS SAEarnings Call TranscriptsGood afternoon, everyone. Welcome to today's Focal Therix second quarter 2026 conference call. At this time, all participants are in a listen-only mode. After the prepared remarks, you will have the opportunity to ask qu
- 3mo agoFOCLFocalTherics™ Reports Second Quarter 2026 Financial ResultsGlobeNewswireFocalTherics™ Reports Second Quarter 2026 Financial Results 39% Revenue Increase and 47% Growth in U.S. Procedures AUSTIN, Texas, Aug. 13, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (NASDAQ:FOCL) (the
- 3mo agoFOCLFocalTherics™ Announces Pricing of Public Offering of American Depositary SharesGlobeNewswireFocalTherics™ Announces Pricing of Public Offering of American Depositary Shares AUSTIN, Texas and LYON, France, Aug. 11, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (NASDAQ:FOCL) (the "Company"), a global leader
- 3mo agoFOCLFocalTherics™ Reports Preliminary Financial Results for Second Quarter of 2026GlobeNewswireFocalTherics™ Reports Preliminary Financial Results for Second Quarter of 2026 AUSTIN, Texas, Aug. 11, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (NASDAQ:FOCL) (the "Company"), a global leader in robotic focal
- 3mo agoFOCLFocalTherics™ Announces Proposed Public Offering of American Depositary SharesGlobeNewswireFocalTherics™ Announces Proposed Public Offering of American Depositary Shares AUSTIN, Texas and LYON, France, Aug. 11, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (NASDAQ:FOCL) (the "Company"), a global leader in
- 3mo agoFOCLFocalTherics™ to Announce Second Quarter 2026 Financial Results on August 13, 2026GlobeNewswireFocalTherics™ to Announce Second Quarter 2026 Financial Results on August 13, 2026 Company to host conference call and webcast on Thursday, August 13 at 4:30 p.m. EDT AUSTIN, Texas, July 30, 2026 (GLOBE NEWSWIRE) --
- 4mo agoFOCLFocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial PatientsGlobeNewswireFocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients AUSTIN, Texas, June 30, 2026 (GLOBE NEWSWIRE) -- FocalTherics™
- 4mo agoFOCLFocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedicalGlobeNewswireFocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical AUSTIN, Texas, June 16, 2026 (GLOBE NEWSWIRE) -- FocalTherics (NASDAQ:FOCL)